E-LIB Suche - Ergebnisse für: Ruetsch-Chelli, C

1

Anti-rituximab antibodies demonstrate neutralising capacity..:

Wincup, C ; Dunn, A ; Ruetsch-Chelli, C...
https://discovery.ucl.ac.uk/id/eprint/10158292/2/Ciurtin_Anti-rituximab%20antibodies%20demonstrate%20neutralising%20capacity,%20associate%20with%20lower%20circulating%20drug%20levels%20and%20earlier%20relapse%20in%20lupus_AOP.pdf. , 2022

Link: https://discovery.ucl.ac..

2

Anti-rituximab antibodies demonstrate neutralizing capacity..:

Wincup, Chris ; Dunn, Nicky ; Ruetsch-Chelli, Caroline...
Rheumatology. 62 (2022) 7 - p. 2601-2610 , 2022

Link: https://doi.org/10.1093/..

3

PO.6.126 Anti-rituximab antibodies demonstrate neutralising..:

N Kharlamova ; D Isenberg ; N Dunn...
https://doaj.org/toc/2053-8790. , 2022

Link: https://doi.org/10.1136/..

4

Sphingosine-1 Phosphate Receptor Modulators Increase In Vit..:

Ruetsch-Chelli, Caroline ; Okuda, Darin T. ; Rocher, Fanny...
Neurology and Therapy. 12 (2022) 1 - p. 289-302 , 2022

Link: https://doi.org/10.1007/..

5

P243 Anti-rituximab antibodies demonstrate neutralising cap..:

Wincup, Chris ; Dunn, Nicky ; Ruetsch-Chelli, Caroline...
Rheumatology. 61 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

6

Low baseline IFN-γ response could predict hospitalization i..:

Cremoni, Marion ; Allouche, Jonathan ; Graça, Daisy...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

Memory B Cells Predict Relapse in Rituximab-Treated Myasthe..:

Ruetsch-Chelli, Caroline ; Bresch, Saskia ; Seitz-Polski, Barbara...
Neurotherapeutics. 18 (2021) 2 - p. 938-948 , 2021

Link: https://doi.org/10.1007/..

8

Baseline and early functional immune response is associated..:

Gérard, Alexandre ; Doyen, Jerome ; Cremoni, Marion...
Journal for ImmunoTherapy of Cancer. 9 (2021) 6 - p. e002512 , 2021

Link: https://doi.org/10.1136/..

9

EPH83 Characteristics, Comorbid Gi Conditions, and Treatmen..:

May, D. ; Ruetsch, C. ; Yang, X...
Value in Health. 26 (2023) 6 - p. S179 , 2023

Link: https://doi.org/10.1016/..

10

EPH196 Prevalence of GI Comorbidities by Age Group Among Pa..:

May, D. ; Ruetsch, C. ; Darer, J....
Value in Health. 26 (2023) 12 - p. S238-S239 , 2023

Link: https://doi.org/10.1016/..

11

PCR110 Characteristics and Comorbid Conditions Associated w..:

Ruetsch, C. ; Parab, P. ; Younglove, C...
Value in Health. 26 (2023) 6 - p. S332 , 2023

Link: https://doi.org/10.1016/..

12

MT12 Changes in Healthcare Resource Utilization in Patients..:

Shah, N ; Velez, F ; Anastassopoulos, K...
Value in Health. 25 (2022) 7 - p. S534 , 2022

Link: https://doi.org/10.1016/..

13

PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Me..:

Pesa, J. ; Liberman, J.N. ; Petrillo, M..
Value in Health. 24 (2021) - p. S132 , 2021

Link: https://doi.org/10.1016/..

14

PMH6 Healthcare Costs Increase Substantially Following Adju..:

Forma, F. ; Liberman, J.N. ; Rui, A..
Value in Health. 24 (2021) - p. S129 , 2021

Link: https://doi.org/10.1016/..

15

P.851Differences in healthcare resource utilization across ..:

Niu, X. ; Dembek, C. ; Williams, G.R..
European Neuropsychopharmacology. 40 (2020) - p. S472-S473 , 2020

Link: https://doi.org/10.1016/..